FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40758611000001108: Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2314501000001116 Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2314521000001111 Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Is a Tapentadol 150mg modified-release capsules true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Is a Tapimio true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tapentadol true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Has specific active ingredient Tapentadol phosphate true Inferred relationship Existential restriction modifier
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) 56 capsule Has AMP True Tapimio 150mg modified-release capsules (Neuraxpharm UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start